β-Blockers and their possible effect on prostate cancer mortality

Data from two studies just published by a team of Norwegian researchers have suggested the possibility that men taking β-blockers for other (e.g., cardiovascular) conditions may have an increased survival benefit compared to other men who are diagnosed with and treated for high-risk or metastatic prostate cancer. … READ MORE …